Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in Amarin Corporation PLC to

Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of 
$100,000 Investing in Amarin Corporation PLC to Contact the
NEW YORK, NY -- (Marketwired) -- 11/15/13 --  Faruqi & Faruqi, LLP, a
leading national securities law firm, reminds investors in Amarin
Corporation PLC ("Amarin" or the "Company") (NASDAQ: AMRN) of the
January 3, 2014 deadline to seek the role of lead plaintiff in a
federal securities class action lawsuit filed against Amarin and
certain executives. 
A complaint has been filed on behalf of all persons who purchased
Amarin common stock between July 9, 2009 and October 15, 2013 (the
"Class Period") in the District of New Jersey. 
The complaint alleges that the Company and its executives violated
federal securities laws with respect to its disclosures concerning
its business, operations, and prospects. 
Specifically, the action alleges that throughout the Class Period,
Amarin issued false and/or misleading statements regarding the
prospects of the FDA approving Vascepa, the Company's lead product.  
On October 16, 2013, Amarin announced that the FDA's Endrocrinologic
and Metabolic Drugs Advisory Committee had voted 9 to 2 against
approval of Vascepa. 
Following this news, the Company's stock declined $3.16 per share, or
over 61%, to close at $2.01 per share on October 17, 2013. 
Request more information now by clicking here:
www.faruqilaw.com/AMRN. There is no cost or obligation to you. 
Take Action 
If you invested in Amarin stock or options between July 9, 2009 and
October 15, 2013 and would like to discuss your legal rights, visit
www.faruqilaw.com/AMRN. You can also contact us by calling Richard
Gonnello or Francis McConville toll free at 877-247-4292 or at
212-983-9330 or by sending an e-mail to rgonnello@faruqilaw.com or
fmcconville@faruqilaw.com. Faruqi & Faruqi, LLP also encourages
anyone with information regarding Amarin's conduct to contact the
firm, including whistleblowers, former employees, shareholders and
Faruqi & Faruqi, LLP is a national law firm which represents
investors and individuals in class action litigation. The firm is
focused on providing exemplary legal services in complex litigation
in the areas of securities, shareholder, antitrust and consumer
litigation, throughout all phases of litigation. The firm has an
experienced trial team which has achieved significant victories on
behalf of the firm's clients. To keep track of the latest securities
litigation news, follow us on Twitter at
www.twitter.com/MergerActivity or on Facebook at
Attorney Advertising. The law firm responsible for this advertisement
is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not
guarantee or predict a similar outcome with respect to any future
matter. We welcome the opportunity to discuss your particular case.
All communications will be treated in a confidential manner. 
369 Lexington Avenue, 10th Floor
New York, NY 10017
Attn: Richard Gonnello, Esq.
Francis McConville, Esq.
Telephone: (877) 247-4292 or (212) 983-9330 
Press spacebar to pause and continue. Press esc to stop.